Education
About Us
Working with TipRanks
Follow Us
Pathfinder Cell Therapy (PFND)
:PFND
PFND Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.02
Previous CloseN/A
Volume2.50K
Average Volume (3M)0.00
Market Cap
$667.00
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.00
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding667,161,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
PFND FAQ
What was Pathfinder Cell Therapy’s price range in the past 12 months?
Pathfinder Cell Therapy lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is Pathfinder Cell Therapy’s market cap?
Pathfinder Cell Therapy’s market cap is $667.00.
When is Pathfinder Cell Therapy’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Pathfinder Cell Therapy’s earnings last quarter?
Currently, no data Available
Is Pathfinder Cell Therapy overvalued?
According to Wall Street analysts Pathfinder Cell Therapy’s price is currently Overvalued.
Does Pathfinder Cell Therapy pay dividends?
Pathfinder Cell Therapy does not currently pay dividends.
What is Pathfinder Cell Therapy’s EPS estimate?
Pathfinder Cell Therapy’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pathfinder Cell Therapy have?
Pathfinder Cell Therapy has 667,161,000 shares outstanding.
What happened to Pathfinder Cell Therapy’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Pathfinder Cell Therapy?
Currently, no hedge funds are holding shares in PFND
Company Description
Pathfinder Cell Therapy
Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage. It identifies diabetes, renal disease, myocardial infarction, peripheral vascular disease, and other diseases as potential indications for therapies based on its technology. The company was founded in 2008 and is headquartered in Cambridge, Massachusetts.
Technical Analysis
TNF Pharmaceuticals
―
Brainstorm Cell Therapeutics
―
Salarius Pharmaceuticals
―
Quoin Pharmaceuticals
―
GRI Bio
―